James K. Fong

Insider Reports History

Entity
Individual
Location
C/O Cti Biopharma Corp, 3101 Western Avenue, Suite 800, Seattle, WA
Signature
/s/ Adam Craig, attorney-in-fact for James K. Fong
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by James K. Fong:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CTI BIOPHARMA CORP EVP & Chief Commercial Officer Common Stock 0 $9.10 Jun 26, 2023 Direct
CTI BIOPHARMA CORP EVP & Chief Commercial Officer Stock Option (Right to Buy) 0 Jun 26, 2023 Direct

Insider Reports Filed by James K. Fong

Symbol Company Period Transactions Value $ Form Type Date Filed Role
CTIC CTI BIOPHARMA CORP Jun 26, 2023 10 -$32.4K 4 Jun 26, 2023 EVP & Chief Commercial Officer
CTIC CTI BIOPHARMA CORP Mar 14, 2023 1 $0 4 Mar 16, 2023 EVP & Chief Commercial Officer
CTIC CTI BIOPHARMA CORP Jan 24, 2023 4 -$505K 4 Jan 26, 2023 EVP & Chief Commercial Officer
CTIC CTI BIOPHARMA CORP Feb 28, 2022 0 $0 3 Mar 11, 2022 Senior Vice President and Chief Commercial Officer Exhibit 24 - Power of Attorney